about
Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profilePrognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma.Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8(+) T cells in vivo.Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio.
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
T cell therapy for nasopharyngeal carcinoma.
@en
T cell therapy for nasopharyngeal carcinoma.
@nl
type
label
T cell therapy for nasopharyngeal carcinoma.
@en
T cell therapy for nasopharyngeal carcinoma.
@nl
prefLabel
T cell therapy for nasopharyngeal carcinoma.
@en
T cell therapy for nasopharyngeal carcinoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
T cell therapy for nasopharyngeal carcinoma
@en
P2093
G Ottonello
G Quartuccio
R Maccario
S Secondino
P2860
P304
P356
10.7150/JCA.2.341
P577
2011-06-03T00:00:00Z